ArticleOPEN ACCESS

Metabolic syndrome and diabetes for the urologist

Journal of the Canadian Urological Association
DOI: 10.5489/cuaj.2314
6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Type 2 diabetes has a number of know urological consequences. Epidemiologic and clinical data suggest a link between metabolic syndrome and prostatic diseases, such as benign prostatic hyperplasia (BPH) and prostate cancer. Recent studies have identified metformin as a viable treatment for patients with type 2 diabetes and prostate cancer.

Cite

CITATION STYLE

APA

Fleshner, N. E., & Bhindi, B. (2014). Metabolic syndrome and diabetes for the urologist. Journal of the Canadian Urological Association. Canadian Medical Association. https://doi.org/10.5489/cuaj.2314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free